Aprea Therapeutics | ARS: Annual Report to Security Holders
Apr 25 07:35 ET
Aprea Therapeutics | DEFA14A: Others
Apr 25 07:20 ET
Aprea Therapeutics | DEF 14A: Definitive information statements
Apr 25 07:05 ET
Aprea Therapeutics | 8-K: Current report
Apr 10 16:19 ET
Aprea Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Apr 3 16:11 ET
Aprea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hamill John P.
Mar 28 18:00 ET
Aprea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Gilad Oren
Mar 28 18:00 ET
Aprea Therapeutics | 8-K: Aprea Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update
Mar 26 08:19 ET
Aprea Therapeutics | 10-K: Annual report
Mar 26 07:49 ET
Aprea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hamill John P.
Mar 14 20:55 ET
Aprea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Seizinger Bernd R.
Mar 14 20:55 ET
Aprea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director HENNEMAN JOHN B III
Mar 14 20:55 ET
Aprea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Gilad Oren
Mar 14 20:55 ET
Aprea Therapeutics | 8-K: Current report
Mar 12 16:35 ET
Aprea Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Sio Capital Management, LLC(7.49%)
Feb 14 08:04 ET
Aprea Therapeutics | 424B3: Prospectus
Feb 9 12:08 ET
Aprea Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-AIGH Capital Management, LLC(9.4%),Orin H(9.4%)
Feb 7 18:57 ET
Aprea Therapeutics | 8-K: Current report
Feb 6 17:03 ET
Aprea Therapeutics | 424B3: Prospectus
Feb 5 12:10 ET
Aprea Therapeutics | EFFECT: Others
Feb 5 06:07 ET
No Data
No Data